Ardian-backed Biofarma Group, a manufacturer of food supplements, medical devices, probiotic-based drugs and cosmetics, completed the acquisition of US Pharma Lab, a pharmaceutical company. Financial terms were not disclosed. “We are delighted to partner with Amol and the US Pharma Lab team. The combination of Biofarma Group and US Pharma Lab will create the only global CDMO fully focused on Nutraceuticals which will be able to offer significant additional benefits to new and existing customers through a broad range of nutraceutical technologies and R&D capabilities, in addition to providing a harmonized service globally," Gianfranco Nazzi, Biofarma Group CEO.